News

Ophthalmology Times44m

Ocular Therapeutix receives FDA agreement under special protocol assessment for registrational trial of AXPAXLI

The agreement is for a planned clinical trial of AXPAXLI (also known as OTX-TKI) for the treatment of non-proliferative ...
Ophthalmology Times57m

Q&A: Understanding the influences on molecular confirmation after genetic testing for IRDs

Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...